ADJUVANT CHEMOTHERAPY FOR STAGE II COLON CANCER FOLLOWING COMPLETE RESECTION: EXPERIENCE OF THE MOHAMMED VI UNIVERSITY HOSPITAL CENTER AT ONCOLOGY CENTER IN MARRAKESH

K. El Bouaouidi*, M. Kaakoua, Kh. Lakloumi, S. El Ouarzazi, M. Elfadli and Rh. Belbaraka

ABSTRACT

Colorectal cancer (CRC) is the third most common cancer and the second cause of cancer deaths for both sexes combined.[1] While the efficacy of chemotherapy for stage III colon cancer is confirmed, it is still controversial for stage II[2–3], For a long time, it has been based on the presence or absence of poor prognostic factors (lymph nodes sampling <12; poorly differentiated tumor; vascular or lymphatic or perineural invasion; tumor presentation with an obstruction or tumor perforation and pT4 stage).

Keywords: .